$ELVN
Enliven Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$46.97
▲+1.64%+$0.759
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEnliven Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ELVN up today? It is at $46.97 (+1.64%), and our scanner flagged it 80 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ELVN spikes, and full due diligence on ELVN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ELVN 80 times in the last 30 days. Create a free account to track $ELVN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ELVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ELVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing144Notice of proposed insider sale (144)Oct 1, 2026 · 3 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Collins Helen Louise Officer | Sold (automatic/other) | -5K | sold 17% | 25K | $250K at $50.03 | Sep 17, 26 |
Collins Helen Louise Officer | Other | 5K | added 20% | 30K | $12K at $2.48 | Sep 17, 26 |
Hohl Benjamin Officer | Sold (automatic/other) | -6K | sold 14% | 38K | $301K at $50.03 | Sep 17, 26 |
Hohl Benjamin Officer | Other | 4K | added 9.9% | 44K | $59K at $14.85 | Sep 17, 26 |
Collins Helen Louise Officer | Sold (automatic/other) | -5K | sold 17% | 25K | $292K at $58.37 | Aug 17, 26 |
Collins Helen Louise Officer | Other | 5K | added 20% | 30K | $12K at $2.48 | Aug 17, 26 |
Hohl Benjamin Officer | Sold (automatic/other) | -6K | sold 13% | 40K | $351K at $58.35 | Aug 17, 26 |
Derynck Mika K Director | Sold (automatic/other) | -159K 0.2% of company | n/a | n/a | $9.6M at $60.21 | Aug 4, 26 |
Derynck Mika K Director | Other | 159K 0.2% of company | n/a | 159K | $394K at $2.48 | Aug 4, 26 |
Collins Helen Louise Officer | Sold (automatic/other) | -5K | sold 17% | 25K | $250K at $50.05 | Jul 17, 26 |
Collins Helen Louise Officer | Other | 5K | added 20% | 30K | $12K at $2.48 | Jul 17, 26 |
Hohl Benjamin Officer | Sold (automatic/other) | -6K | sold 12% | 46K | $301K at $49.97 | Jul 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ELVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ELVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ELVN last traded at $46.97, up 1.64% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Enliven Therapeutics, Inc. Common Stock (ELVN) is next expected to report earnings on Wednesday, November 11, 2026, about 38 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ELVN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ELVN 80 times in the last 30 days.
ELVN (Enliven Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.44B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ELVN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ELVN discussion
Sign in to ask a question or join the discussion.